Literature DB >> 6644025

Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.

S J Ackerman, D A Loegering, P Venge, I Olsson, J B Harley, A S Fauci, G J Gleich.   

Abstract

The human eosinophil granule contains a number of cationic proteins that have been identified and purified to homogeneity, including the major basic protein (MBP), the eosinophil cationic protein (ECP), and the eosinophil-derived neurotoxin (EDN). Because of confusion in the literature regarding the distinctiveness of MBP and ECP, we investigated the immunochemical and physicochemical properties of these purified proteins by electrophoresis on sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE), by specific double antibody radioimmunoassays (RIA) for MBP and ECP, and by fractionation of acid-solubilized eosinophil granules on Sephadex G-50 columns. Analysis of a mixture of the three purified proteins by SDS-PAGE showed that they migrated as three distinct bands with differing m.w. Comparison by specific RIA for MBP and ECP did not demonstrate any appreciable immunochemical cross-reactivities among the three proteins. Sephadex G-50 column fractions of acid-solubilized eosinophil granules were analyzed by RIA and by SDS-PAGE analysis of individual column fractions. MBP, ECP, and EDN eluted at different volumes from Sephadex G-50 columns as determined by RIA and SDS-PAGE. Soluble extracts of eosinophil granules from patients with the hypereosinophilic syndrome contained between six and 64 times more MBP than ECP on a weight basis. These observations demonstrate that MBP, ECP, and EDN are distinctive cationic proteins of the human eosinophil granule and that eosinophil granules from patients with eosinophilia contain considerably greater quantities of MBP than ECP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644025

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  RNase A ribonucleases and host defense: an evolving story.

Authors:  Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2008-01-22       Impact factor: 4.962

3.  Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Biochemistry       Date:  2011-09-07       Impact factor: 3.162

Review 4.  Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue.

Authors:  F J van Overveld
Journal:  Agents Actions       Date:  1990-04

5.  Immunohistochemical detection of deposits of eosinophil-derived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas' disease.

Authors:  H A Molina; F Kierszenbaum
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.

Authors:  Sharmilee M Nyenhuis; Preeth Alumkal; Jian Du; Brian T Maybruck; Mark Vinicky; Steven J Ackerman
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

7.  Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.

Authors:  A J Coyle; S J Ackerman; R Burch; D Proud; C G Irvin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Eosinophil granule cationic proteins regulate the classical pathway of complement.

Authors:  J M Weiler; R E Edens; C S Bell; G J Gleich
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

Review 9.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

10.  FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.

Authors:  D J Mulder; I Pacheco; D J Hurlbut; N Mak; G T Furuta; R J MacLeod; C J Justinich
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.